Tumor necrosis factor-alpha and receptors for it in labial salivary glands in Sjögren's syndrome

Clinical and Experimental Rheumatology

Volumn 19, Issue 2, 2001, Pages 131-137

  Koski, H ^a   Janin, A ^a   Humphreys Beher, M G ^a   Sorsa, T ^a   Malmstrom M ^a   Konttinen, Y T ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Acinar cell; Apoptosis; Atrophy; Receptor; Sj gren's syndrome; TNF

Indexed keywords

HYBRID PROTEIN; IMMUNOGLOBULIN FC FRAGMENT; LIGAND; NEUTRALIZING ANTIBODY; PROTEIN P55; PROTEIN P75; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR;

ACINAR CELL; ARTICLE; ATROPHY; CELL INFILTRATION; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOSTASIS; CYTOTOXICITY; ENDOTHELIUM CELL; EPITHELIUM CELL; FIBROBLAST; FIBROSIS; HUMAN; HUMAN TISSUE; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; INFLAMMATION; INFLAMMATORY CELL; LIP; MITOGENICITY; MONONUCLEAR CELL; PEROXIDASE ANTIPEROXIDASE COMPLEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; RHEUMATIC DISEASE; SALIVARY GLAND; SALIVARY GLAND DUCT; SIALOADENITIS; SJOEGREN SYNDROME; TARGET CELL; VASCULAR ENDOTHELIUM;

ANTIGENS, CD; APOPTOSIS; ATROPHY; BIOPSY; HUMANS; IMMUNOENZYME TECHNIQUES; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; SALIVARY GLANDS; SJOGREN'S SYNDROME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0035042244     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Salivary gland acinar epithelial cells are deficient in their protein kinase C expression in Sjögren's syndrome
2. Pathogenesis of Sjögren's syndrome
3. The expanding universe of T-cell subsets: Th1, Th2 and more
4. Cachectin and tumor necrosis factor as two sides of the same biological coin
5. Cytokine mRNA expression in salivary gland biopsies of Sjögren's syndrome
6. Expressions of cytokine genes during development of autoimmune sialadenitis in MRL/lpr mice
7. The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response
8. Functional activities of receptors for tumor necrosis factor-alpha on human vascular endothelial cells
9. Local cytokine expression in the progression toward B cell malignancy in Sjögren's syndrome
10. Tumor necrosisfactor receptor distribution in human lymphoid tissue
11. TNF receptor distribution in human tissues
12. Interferon-gamma induced cell death in a cultured human salivary gland cell line
13. Fibroblast growth enhancing activity of tumor necrosis factor and its relationship to other polypeptide growth factors
14. Localization of tumor necrosis factor receptors in the synovial tissue and cartilage-pannus junction in patients with rheumatoid arthritis
15. Tumor necrosis factor (TNF)-α directly inhibits human erythropoiesis in vitro: Role of p55 and p75 TNF receptors
16. Preliminary criteria for the classification of Sjögren's syndrome. Result of a prospective concerted action supported by the European Community
17. The unlabelled antibody enzyme method for immunohistochemistry. Preparation and properties of soluble antigen-antibody complex (horseradish peroxidase-antihorseradish peroxidase) and its use in identification of spirochetes
18. Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies
19. Tumor necrosis factor receptors in lymphoid tissues and lymphomas: Source and site of action of tumor necrosis factor alpha
20. Production of interleukin 2 (IL 2) by salivary gland lymphocytes in Sjögren's syndrome. Detection of reactive cells by using antibody directed to synthetic peptides of IL 2
21. T and B lymphocytes in peripheral blood and tissue lesions in Sjögren's syndrome
22. Analysis of the defects responsible for the impaired regulation of Epstein-Barr virus-induced B cell proliferation by rheumatoid arthritis lymphocytes. I. Diminished gamma interferon production in response to autologous stimulation
23. Regulation of the growth of Epstein-Barr virus infected B cells. I. Growth regression by E-rosetting cells from VCA-positive donors is a combined effect of autologous mixed leukocyte reaction and activation of T8 memory cells
24. Cytokine mRNA expression in the labial salivary gland tissues from patients with Sjögren's syndrome
25. Analysis of transforming growth factor beta and other cytokines in autoimmune exocrinopathy (Sjögren's syndrome)
26. Cytokine messenger RNA expression in the labial salivary glands of patients with Sjögren's syndrome
27. T lymphocyte activation state in the minor salivary glands of patients with Sjögren's syndrome
28. TNF α in rheumatoid arthritis and prospects of anti-TNF therapy
29. HLA-DR expression by labial salivary glands in Sjögren's syndrome
30. Expression of cell adhesion molecules in the salivary and lacrimal glands of Sjögren's syndrome
31. Expression and regulation of matrix metalloproteinase-8 in synovial fibroblasts and endothelial cells
32. Collagenase in Sjögren's syndrome
33. Bendtzen Cytokine expression in labial salivary glands from patients with primary Sjögren's syndrome
34. Evaluation and management of scleroderma lung disease using bronchoalveolar lavage
35. Peptide-containing nerves in labial salivary glands in Sjögren's syndrome
36. Distribution of vasoactive intestinal peptide (VIP) and its binding sites in labial salivary glands in Sjögren's syndrome and in normal controls
37. VIP in salivary glands in Sjögren's syndrome
38. Role of cytokines in the destructive of acinar structure in Sjögren's syndrome salivary glands
39. Prevention of autoimmune diabetes mellitus in NOD mice by transgenic expression of soluble tumor necrosis factor receptor p55